GSK plc

NYSE:GSK Stock Report

Market Cap: US$102.8b

GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSE:GSK Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Feb 26SellUS$3,999,951Harold BarronIndividual67,601US$59.17
19 Dec 25BuyUS$35,445Vishal SikkaIndividual730US$48.56
19 Dec 25BuyUS$9,760Harry DietzIndividual201US$48.56
19 Dec 25BuyUS$9,760Anne BealIndividual201US$48.56
19 Dec 25BuyUS$76,571Charles BancroftIndividual1,577US$48.56
19 Dec 25BuyUS$9,808Tsun-Huei LeeIndividual202US$48.56
19 Dec 25BuyUS$9,760Elizabeth AndersonIndividual201US$48.56
14 Nov 25BuyUS$132,191Harold BarronIndividual2,801.84US$47.18
19 Sep 25BuyUS$33,691Vishal SikkaIndividual827US$40.74
19 Sep 25BuyUS$9,777Harold BarronIndividual240US$40.74
19 Sep 25BuyUS$9,777Harry DietzIndividual240US$40.74
19 Sep 25BuyUS$9,777Anne BealIndividual240US$40.74
19 Sep 25BuyUS$76,589Charles BancroftIndividual1,880US$40.74
19 Sep 25BuyUS$9,737Tsun-Huei LeeIndividual239US$40.74
19 Sep 25BuyUS$9,777Elizabeth AndersonIndividual240US$40.74

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GSK?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,525,8030.0381%
Individual Insiders2,418,6490.0604%
State or Government5,358,1120.134%
Private Companies47,310,5041.18%
Employee Share Scheme67,995,8981.7%
General Public405,468,99010.1%
Institutions3,476,933,29086.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 51.84% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.4%
BlackRock, Inc.
376,834,226US$9.7b-6.81%0.11%
4.84%
Dodge & Cox
194,039,468US$5.0b-12.8%1.31%
4.15%
FMR LLC
166,174,321US$4.3b-3.7%0.19%
3.12%
Vanguard Capital Management, LLC
125,048,915US$3.2b1.65%0.06%
2.85%
Wellington Management Group LLP
114,138,839US$2.9b5.8%0.44%
2.44%
State Street Global Advisors, Inc.
97,947,292US$2.5b0.81%0.07%
2.13%
Fisher Asset Management, LLC
85,416,664US$2.2b2.51%0.66%
2.03%
Strategic Advisers LLC
81,207,760US$2.1b0.38%0.5%
1.99%
UBS Asset Management AG
79,766,097US$2.0b-5.21%0.14%
1.7%
GlaxoSmithKline Employee Trust
67,995,898US$1.7b-3.09%no data
1.63%
Legal & General Investment Management Limited
65,307,145US$1.7b-4.48%0.29%
1.54%
Norges Bank Investment Management
61,556,259US$1.6b-2.93%0.09%
1.46%
Schroder Investment Management Limited
58,522,954US$1.5b-2.16%0.67%
1.32%
Vanguard Asset Management, Limited
52,963,383US$1.4b1.73%0.46%
1.31%
Amundi Asset Management SAS
52,564,331US$1.3b27.5%0.19%
1.26%
PRIMECAP Management Company
50,409,076US$1.3b0.3%0.8%
1.24%
Aberdeen Group Plc
49,835,755US$1.3b-0.6%0.62%
1.11%
HSBC Global Asset Management (UK) Limited
44,479,712US$1.1b14.1%0.34%
1.02%
GlaxoSmithKline plc, Shareview Client
40,837,103US$1.0b-2.54%no data
1.02%
Geode Capital Management, LLC
40,713,422US$1.0b6.78%0.05%
0.96%
Mondrian Investment Partners Limited
38,652,652US$991.3m-18.1%7.28%
0.91%
Massachusetts Financial Services Company
36,362,189US$932.6m2,900%0.2%
0.88%
Vanguard Fiduciary Trust Company
35,350,749US$906.6m1.26%0.11%
0.78%
Columbia Management Investment Advisers, LLC
31,190,973US$799.9m8.83%0.14%
0.74%
Hargreaves Lansdown Asset Management Ltd.
29,787,026US$763.9m-1.57%1.4%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/04 01:26
End of Day Share Price 2026/08/03 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

GSK plc is covered by 47 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John EadeArgus Research Company
Odile RundquistBaader Helvea Equity Research
Xue ChenBarclays